Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Qol Holdings Co., Ltd.
  6. Summary
    3034   JP3266160005

QOL HOLDINGS CO., LTD.

(3034)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Japan Exchange
01/17/2022 01/18/2022 01/19/2022 01/20/2022 01/21/2022 Date
1356(c) 1332(c) 1281(c) 1285(c) 1311(c) Last
24 200 74 100 111 500 62 600 34 800 Volume
-0.51% -1.77% -3.83% +0.31% +2.02% Change
More quotes
Estimated financial data (e)
Sales 2022 173 B 1 524 M 1 524 M
Net income 2022 5 500 M 48,4 M 48,4 M
Net Debt 2022 9 383 M 82,5 M 82,5 M
P/E ratio 2022 8,90x
Yield 2022 2,14%
Sales 2023 183 B 1 608 M 1 608 M
Net income 2023 6 000 M 52,8 M 52,8 M
Net Debt 2023 8 155 M 71,7 M 71,7 M
P/E ratio 2023 8,12x
Yield 2023 2,14%
Capitalization 48 140 M 423 M 423 M
EV / Sales 2022 0,33x
EV / Sales 2023 0,31x
Nbr of Employees 5 517
Free-Float 57,2%
More Financials
Company
Qol Holdings Co.,Ltd., formerly Qol Co., Ltd. is engaged in the operation of insurance pharmacies and Business Process Outsourcing (BOP) commission business. The Company operates in two segments. The Insurance Pharmacy segment is engaged in the operation of insurance pharmacies, as well as the operation of convenience stores in hospitals. The BOP Commission segment is engaged in the Contract Sales Organization (CSO)... 
Sector
Drug Retailers
Calendar
02/04Earnings Release
More about the company
Ratings of Qol Holdings Co., Ltd.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about QOL HOLDINGS CO., LTD.
01/21Alnylam Pharmaceuticals Says Vutrisiran Met All Secondary Endpoints from HELIOS-A Phase..
MT
2021Consolidated Financial Results for the Six Months Ended September 30, 2021
PU
2021Qol Holdings Co., Ltd. Announces Second Quarter End Dividend for the Fiscal Year Ending..
CI
2021Qol Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Endi..
CI
2021QOL HOLDINGS CO., LTD. : Ex-dividend day for interim dividend
FA
2021Qol Holdings Co., Ltd. Provides Dividend Guidance for the Second Quarter and Full Year ..
CI
2021Qol Holdings Co., Ltd. Provides Financial Guidance for the Six Months Ended September 3..
CI
2021Qol Holdings Co., Ltd. Announces Consolidated Financial Results for the First Quarter E..
CI
2021Qol Holdings Co., Ltd. acquired KI Chozai Yakkyoku Ltd.
CI
2021QOL HOLDINGS CO., LTD. : Ex-dividend day for final dividend
FA
2021Qol Holdings Co., Ltd. Provides Dividend Guidance for the Year Ending March 31, 2021
CI
2021Qol Holdings Co., Ltd. Provides Financial Guidance for the Year Ending March 31, 2021
CI
2021Qol Holdings Co., Ltd. Announces Consolidated Financial Results for the Nine Months End..
CI
2021Qol Holdings Co., Ltd. acquired Katsuharaku Pharmacy Co., Ltd.
CI
2020Qol Holdings Co., Ltd. Revises Earnings Guidance for the Second Quarter of the Fiscal Y..
CI
More news
News in other languages on QOL HOLDINGS CO., LTD.
01/21Alnylam Pharmaceuticals déclare que le Vutrisiran a satisfait à tous les critères secon..
2021Qol Holdings Co., Ltd. annonce le versement d'un dividende de fin de deuxième trimestre..
2021Qol Holdings Co., Ltd. fournit des prévisions de bénéfices consolidés pour l'exercice s..
2021Qol Holdings Co., Ltd. fournit des prévisions de dividendes pour le deuxième trimestre ..
2021Qol Holdings Co., Ltd. fournit des prévisions financières pour les six mois se terminan..
More news
Chart QOL HOLDINGS CO., LTD.
Duration : Period :
Qol Holdings Co., Ltd. Technical Analysis Chart | 3034 | JP3266160005 | MarketScreener
Technical analysis trends QOL HOLDINGS CO., LTD.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 1 311,00 JPY
Average target price 2 250,00 JPY
Spread / Average Target 71,6%
EPS Revisions
Managers and Directors
Takashi Nakamura Representative Director & Vice President
Kiyonobu Fukumitsu Executive Officer
Masaru Nakamura Chairman
Toshiko Kuboki Independent Outside Director
Yukiharu Yamamoto Independent Outside Director
Sector and Competitors
1st jan.Capi. (M$)
QOL HOLDINGS CO., LTD.-6.36%423
RAIA DROGASIL S.A.-13.54%6 388
AIN HOLDINGS INC.0.70%1 781
RITE AID CORPORATION-28.11%572
PETMED EXPRESS, INC.-4.95%485
HLS THERAPEUTICS INC.-0.33%387